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Abstract
Background: The ethics of hastened death are complex. Studies on physicians’ opinions about assisted dying
(euthanasia or assisted suicide) exist, but changes in physicians’ attitudes towards hastened death in clinical
decision-making and the background factors explaining this remain unclear.
The aim of this study was to explore the changes in these attitudes among Finnish physicians.
Methods: A questionnaire including hypothetical patient scenarios was sent to 1182 and 1258 Finnish physicians in
1999 and 2015, respectively. Two scenarios of patients with advanced cancer were presented: one requesting an
increase in his morphine dose to a potentially lethal level and another suffering a cardiac arrest. Physicians’ attitudes
towards assisted death, life values and other background factors were queried as well. The response rate was 56%.
Results: The morphine dose was increased by 25% and 34% of the physicians in 1999 and 2015, respectively (p < 0.
001). Oncologists approved the increase most infrequently without a significant change between the study years (15% vs.
17%, p = 0.689). Oncological specialty, faith in God, female gender and younger age were independent factors associated
with the reluctance to increase the morphine dose. Euthanasia, but not assisted suicide, was considered less
reprehensible in 2015 (p = 0.008). In both years, most physicians (84%) withheld cardiopulmonary resuscitation.
Conclusion: Finnish physicians accepted the risk of hastening death more often in 2015 than in 1999. The physicians’
specialty and many other background factors influenced this acceptance. They also regarded euthanasia as
less reprehensible now than they did 16 years ago.
Keywords: Clinical ethics, Decision-making, End-of-life care, Euthanasia
Background
Discussions about the ethical justification of hastened
death due to unbearable suffering are ongoing. Assisted
death through euthanasia or physician-assisted suicide
(PAS) has been legalized in seven countries (five states
in the United States of America) thus far [1]. In addition,
public support for euthanasia and PAS is mounting all
over Western Europe, while some decline has been ob-
served in the United States of America and Eastern Europe
[1, 2]. Today, there are debates about the legalization of
euthanasia in many countries, including Finland, where the
government is currently considering options after a civil
motion demanding the legalization of euthanasia. At
the same time, the importance of palliative care and
patient-centred decision- making has been increasingly
recognized among health care professionals and the gen-
eral public in European countries including Finland [3–9].
Palliative care, by definition, intends to neither hasten
nor postpone death [10]. The International Association for
Hospice and Palliative Care and the European Association
for Palliative Care have recently stated that euthanasia and
PAS should not be included as part of the clinical practice
of palliative care [11, 12]. Attitudes among physicians
towards assisted death are not widely studied, but sev-
eral surveys do demonstrate a lower amount of support
from physicians for euthanasia and PAS when com-
pared to support from the general public [1].
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Questions about hastening death in end-of-life care
are complex and may include ethical concerns broader
than just euthanasia or PAS. Although clear definitions
have been specified for euthanasia and PAS [12], which
lead to a clearly assisted death, the term “hastened death”
is unspecified and has many interpretations. The termin-
ation of life-sustaining treatments may be confused with
euthanasia and PAS among the public and physicians [13].
The term “double effect” has been used when the act
intended to do good (e.g., relief of suffering) justifies the
foreseeable danger of harm (e.g., hastened death) [14].
The use and dosing of opioids during end-of-life care is a
commonly used example when talking about the double
effect: does the intent to treat pain or breathlessness out-
weigh the risk of potentially hastening death [15, 16]?
However, there is growing evidence that even though
high doses of opioids may cause respiratory depression
[17–19], they do not seem to hasten death during
end-of-life care [20, 21]. In a large multinational study
by Miccinesi et al., there was general approval for alle-
viating symptoms with a possibly life-shortening treat-
ment [22]. In another study from the United Kingdom
(UK), physicians reported that they had at least some
intention to hasten death in 7.4% of the deaths evalu-
ated [23]. Physicians’ attitudes towards hastened death
through a dual effect and the background factors influ-
encing these decisions remain largely unknown.
The aims of our study were to elucidate how, if at all,
the attitudes and values towards assisted death among
Finnish physicians have changed over the past 16 years
and to determine the attitudes and background factors
affecting physicians’ willingness to accept hastened death
in a hypothetical patient scenario.
Methods
Participants
A postal survey was conducted in spring 1999 and in
autumn 2015. In both years, the questionnaire was sent
to 500 general practitioners (GPs), 300 surgeons, and
300 internists randomly selected from the register of
the Finnish Medical Association and to all Finnish oncolo-
gists (n = 82 in 1999 and n = 158 in 2015). Reminders were
sent twice to non-respondents. A cover letter including an
introduction to the study and an assurance of anonymity
was mailed together with the questionnaire. It was also
stated in the cover letter, that answering to the question-
naire was completely voluntary. This study was approved
by the Regional Ethics Committee of Tampere University
Hospital, Finland (R15101).
Questionnaire
The questionnaire included seven hypothetical patient
scenarios. Following the patient scenarios, attitudes re-
garding several moral and ethical aspects were assessed
with a 100-mm visual analogue scale (VAS) from “definitely
agree” (0 mm) to “definitely disagree” (100 mm). These
included, for example, statements concerning euthanasia,
palliative care, the role of religion in ethical decisions, ad-
vanced care directives and health care economics together
with physicians’ satisfaction with their own health, work
and salary (Tables 2 and 3). Physicians’ personal concep-
tions of professional status and their own health, family life,
religion, and nature and standard of living were assessed
using a four-point Likert scale (Table 2). The questionnaire
has been previously used and validated with Finnish physi-
cians [24–26].
Patient scenarios
In this study, we included two patient scenarios:
In scenario 1, a 60-year-old male patient is suffering
from prostatic cancer with metastases. Metastases in
the thoracic spine led to total paraparesis 1 month
earlier. There is no hope for a cure. The patient is
well aware of the situation. He has totally lost his
will to live. When you are together with him alone,
he asks for a sufficient dose of morphine to “get
away”. You have denied the overdose, explaining that
it is against your ethical principles. During the fol-
lowing days, you notice that the patient asks you to
double his morphine dose because of unbearable
pain. The anti-inflammatory pain medication is at its
maximum dose and you suspect if the pain is real
(this sentence was removed from the scenario in
2015 as it did not comply with current treatment
guidelines for cancer pain). You suppose that in-
creasing the dose in such a way would lead to the
patient’s death. Your decision is which of the follow-
ing: a) to raise the dose because the patient has the
right to sufficient pain relief in this end-of-life (ter-
minal) care situation; b) to try to help the patient in
other ways, such as with antidepressants, thus con-
tinuing with morphine dosing according to given
guidelines; c) I can’t say; or d) give another
solution:_______________________.
In scenario 2, a 32-year-old female patient is brought
by ambulance to the emergency unit. She is accompanied
by her husband who says his wife has inoperable brain
cancer. She has been receiving maximum radiotherapy,
but this was discontinued 3 weeks ago. She has deterio-
rated considerably during the past week. The patient has
now had an epileptic seizure and has been unconscious
since the attack. After 20 min at the hospital the patient
stops breathing, and there is no pulse. Your treatment
decision is which of the following: a) to start cardiopul-
monary resuscitation (CPR) or b) to withhold CPR.
Piili et al. BMC Medical Ethics  (2018) 19:40 Page 2 of 10
Statistical analysis
The answers concerning the doubling of the morphine dose
in scenario 1 were converted to two options: “I accept” (re-
sponse a) and “I do not accept” (other solutions). The an-
swers on the 4- point Likert scale concerning values were
converted to the following 2-point scale: 1–2 for “not
important” and 3–4 for “important”.
Two-scale background factors and values were tested
using the Pearson chi-square test.
Continuous variables were tested using an indepen-
dent-variables t-test or the Mann-Whitney U- test if the data
were not normally distributed. Two-sided p-values less than
0.05 were considered as statistically significant.
Logistic regression analysis
A forward stepwise logistic regression was used to create
a model explaining the decision to increase the morphine
dose. Background factors, life values, and attitudes, shown
in Table 2, were all included in the model. The p-value
limit for significance was set at 0.10 to enter and 0.15 to
remove from the model.
Data analyses were performed using IBM SPSS Statis-
tics for Windows, Version 23.0 (Armonk, NY: IBM Corp.
Released 2014).
Results
In total, 1373 valid responses were received (response
rate 56%). Characteristics of the physicians according
to the year of response are shown in Table 1. Com-
pared to respondents in 1999, respondents in 2015
were older (p < 0.001), had longer working experience
(p < 0.001) and were more often women (p < 0.001).
Change in attitudes
The attitudes, personal factors and life values of the
responding physicians in 1999 and 2015 are shown
in Table 2.
Euthanasia and withdrawal of life-sustaining treatments
were considered slightly less reprehensible in 2015 than in
1999, whereas attitudes towards assisted suicide did not
change significantly. In 2015, physicians more often be-
lieved that good palliative care enables a good death and
found end-of-life care satisfying, although they were less
often actually involved in end-of-life care than the respon-
dents in 1999. Advance directives were considered more
helpful in 2015, although physicians still rarely had their
own advance directives. The impact of physicians’ back-
ground factors, faith in God, and religion on ethical deci-
sions decreased between 1999 and 2015. The length of
life, family, and cleanliness of environment were thought
to be more important in 2015, while success in their pro-
fessional career was less important.
Change in decision-making
In the case in scenario 1, physicians were significantly
more willing to increase the morphine dose in 2015
(n = 219, 34%) than in 1999 (n = 180, 25%) (p < 0.001).
This willingness increased in all groups of physicians,
except among oncologists, who were also the most
unwilling to do this in both years (Fig. 1). In contrast,
84% of the physicians decided to withhold CPR in case sce-
nario 2 in both years. There were no significant changes
regarding this decision about CPR among the different
physician groups between the study years.
Factors associated with physicians’ willingness to increase
the morphine dose
Difference in the attitudes of physicians who accepted
and those who did not accept the doubling of the mor-
phine dose in both years studied are shown in Table 3.
In 1999, leniency towards euthanasia and assisted sui-
cide was significantly greater in those who accepted the
dose increase, while this was true only for assisted suicide
in 2015.
Religion had a significantly larger influence on
decision-making in physicians who accepted the mor-
phine dose increase in 1999 but not in 2015.
Factors and attitudes that independently influenced
physicians’ willingness to increase the morphine dose
from the logistic regression analysis are shown in Table 4.
Not being an oncologist was the most striking factor
associated with physicians’ willingness to increase the
morphine dose. In addition, physicians who were male,
were older, did not believe in God, accepted assisted sui-
cide, had doubts about physicians’ ability to assess cancer
pain, and responded in 2015 were also more likely to be
willing to increase the morphine dose. However, physicians’
decisions about CPR for the patient in scenario 2 and
their attitudes towards euthanasia or withdrawal of
life-sustaining treatments did not influence their deci-
sion to accept the escalation of the morphine dose.
Discussion
Our study shows that some Finnish physicians’ attitudes
and life values have changed substantially during the last
16 years. Their approval of euthanasia has slightly in-
creased, whereas their acceptance of physician-assisted
suicide (PAS) has remained low. In an end-of-life patient
case scenario, physicians show an increasing willingness
to give a high morphine dose, which might potentially
hasten death. In logistic regression analysis, not being an
oncologist, being male, and not believing in God were
the most important background factors associated with
physicians’ willingness to increase the morphine dose.
In our study Finnish physicians were less opposed to
euthanasia now than they were 16 years ago. This find-
ing is in agreement with previous studies showing
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increased acceptance of euthanasia in Europe as well as
in Finland [1, 2]. However, attitudes towards euthanasia
were measured with a continuous visual analogue scale
(VAS) on a scale from 0 mm (reprehensible) to 100 mm
(not reprehensible) in our study rather than with a di-
chotomous question (i.e., if the physician accepts or does
not accept euthanasia).
Although using a VAS scale might have caused some
confusion, doctors are generally familiar with its use.
This type of assessment might provide more appropriate
insight into this complex ethical question. Of note, the
VAS median value in 2015 was still only 25 mm and the
absolute difference compared to the value in 1999 was
8 mm. Thus, our results highlight the controversial atti-
tude towards euthanasia, which might not be found in
earlier studies; for example, a previous study showed
that 46% of Finnish physicians supported legalization of
euthanasia [2].
In contrast to other studies [1], Finnish physicians
considered PAS even more reprehensible than euthan-
asia and this has not changed at all during the past 16
years. Determining whether this somewhat conflicting
result is due to a true difference in the attitudes towards
these two procedures or just less knowledge about the
process of PAS in Finland could be an aim of future
research.
Table 2 Attitudes, background factors and life values of the physicians in 1999 and 2015
1999 2015 P-values*
Attitudes, median VAS (IQR)
Active euthanasia is reprehensible 17 (6–51) 25 (5–66) 0.008
Withdrawal of life-sustaining treatments is reprehensible 89 (76–95) 93 (76–99) < 0.001
Assisted suicide is reprehensible 14 (5–38) 13 (2–52) 0.480
End-of-life care is satisfying 36 (19–52) 15 (3–35) < 0.001
People should pay costs of factitious diseases by themselves 44 (27–72) 78 (46–93) < 0.001
Advance directives have been helpful in my decisions 35 (14–54) 10 (2–29) < 0.001
Good palliative care enables good death 17 (9–28) 4 (1–12) < 0.001
Physicians can’t estimate cancer pain 40 (25–70) 47 (27–72) 0.042
Religion has influence when I make ethical decisions 65 (31–93) 81 (47–98) < 0.001
Being a doctor gives me satisfaction 20 (11–30) 7 (2–18) < 0.001
My health is excellent 20 (10–32) 14 (6–26) < 0.001
I feel burn out, tired to work 84 (63–94) 89 (71–97) < 0.001
I’m pleased with my salary 72 (37–87) 22 (7–50) < 0.001
It is waste of resources to treat patients > 80 years in ICU 73 (49–86) 77 (54–93) < 0.001
Background factors and life values, n (%)
Having children 600 (85) 555 (88) 0.057
Having own advance directive 38 (5) 38 (6) 0.668
Taking care of end-of-life patients in practice (last 2 years) 529 (75) 418 (65) < 0.001
Taking care of a family member in end-of-life 513 (73) 314 (49) < 0.001
Being afraid of death (Fear-of-death index) 580 (80) 544 (86) 0.006
Length of life is important 412 (59) 524 (87) < 0.001
Health is important 711 (99) 610 (99) 0.027
Family is important 686 (95) 607 (99) < 0.001
Clean environment is important 666 (93) 599 (98) < 0.001
High standard of living is important 358 (50) 398 (65) < 0.001
Faith in God is important 338 (48) 253 (42) 0.024
Success in professional career is important 639 (89) 377 (62) < 0.001
VAS visual analogue scale
IQR interquartile range
ICU intensive care unit
*Mann-Whitney u-test for attitudes and Pearson Chi-Square for background factors and life values
Attitudes are expressed on a visual analogue scale (VAS) from 0 mm (definitely agree) to 100 mm (definitely disagree)
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We asked if euthanasia or assisted suicide were repre-
hensible or not with a VAS scale to evaluate the personal
ethical attitudes of the physicians rather than their opin-
ions on the general justification of these issues. Therefore,
our results represent somewhat different aspect of these
issues compared to the findings of studies that inquired
about physicians’ opinions on the legalization of euthan-
asia or PAS. This might partly explain the differences in
the results of the present and previous studies [1, 2].
According to this study, Finnish physicians do not
consider withdrawal of life-supporting treatments repre-
hensible. Although there was a statistically significant
change between the study years, the absolute difference
was only 4 mm. Our results are in line with the results
from a large, international study by Löfmark et al. where
72–86% of the physicians surveyed reported experien-
cing foregoing life-supporting treatment and only 1–6%
reported never being willing to do so [27].
Table 3 Attitudes of physicians who were willing or unwilling to increase the morphine dose in 1999 and 2015
1999
Increasing the morphine dose
2015
Increasing the morphine dose
Attitudes, median VAS (IQR) Yes No P-value* Yes No P-value*
Active euthanasia is reprehensible 37 (11–69) 14 (5–39) < 0.001 33 (5–72) 24 (4–64) 0.162
Withdrawal of life-sustaining treatments is reprehensible 92 (83–96) 88 (72–95) 0.003 95 (80–99) 93 (75–98) 0.133
Assisted suicide is reprehensible 27 (9–61) 11 (4–28) < 0.001 28 (2–68) 10 (1–49) < 0.001
End-of-life care is satisfying 38 (19–51) 34 (18–52) 0.683 16 (2–30) 14 (3–45) 0.363
People should pay costs of factitious diseases by themselves 40 (23–65) 47 (29–75) 0.047 78 (49–94) 77 (47–93) 0.341
Advance directives have been helpful in my decisions 31 (10–55) 36 (15–54) 0.199 12 (2–29) 10 (2–28) 0.723
Good palliative care enables good death 19 (10–25) 16 (9–29) 0.833 4 (1–13) 4 (1–13) 0.869
Physicians can’t estimate cancer pain 35 (22–70) 41 (27–71) 0.056 44 (23–69) 50 (29–74) 0.006
Religion has influence when I make ethical decisions 77 (44–94) 57 (30–92) 0.040 86 (49–98) 78 (45–98) 0.130
Being a doctor gives me satisfaction 21 (11–29) 19 (11–30) 0.456 7 (1–19) 7 (2–18) 0.928
My health is excellent 21 (10–35) 20 (10–31) 0.273 15 (5–27) 14 (06–25) 0.751
I feel burn out, tired to work 84 (68–93) 84 (62–94) 0.701 88 (75–96) 89 (70–97) 0.843
I’m pleased with my salary 77 (51–90) 70 (35–87) 0.082 22 (8–50) 22 (7–51) 0.759
It is waste of resources to treat patients over 80 years of
age in ICU
70 (48–86) 73 (49–87) 0.262 82 (54–94) 75 (54–91) 0.107
VAS visual analogue scale
IQR interquartile range
ICU intensive care unit
*Mann-Whitney U-test
Attitudes expressed on a visual analogue scale (VAS) from 0 mm (definitely agree) to 100 mm (definitely disagree)
Fig. 1 Proportion of respondents who were willing to increase the morphine dose among different physician groups in 1999 and 2015
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Knowledge about the benefits of palliative care has
grown in recent decades, and it is considered a part of
everyday care in life-threatening illnesses [10, 28, 29].
Therefore, it is not surprising that almost all of the re-
spondents in 2015 considered palliative care as a way of
enabling a good death. However, in another study only
51–70% of physicians believed that palliative care was
able to prevent the need for euthanasia and PAS [22].
Although advanced care planning has shown a positive
impact on the quality of end-of-life care [30, 31], the
prevalence of advance directives varies largely. In the
United States, the prevalence of advance directives seems
to have increased from approximately 10% up to 21–55%
among the elderly in the last 10 years [32, 33], while a
Finnish study from 2004 showed that only 12% of the
home-dwelling elderly had a living will [34]. In our study,
physicians found the advance directives of the patients
now more helpful than they were in 1999, but having an
advance directive of their own was still uncommon among
doctors in 2015 even though they were older and more
experienced than in 1999. This finding might reflect a
division between personal life values and experiences
in clinical work.
In general, physicians accepted potentially lethal mor-
phine dosing more frequently now than in 1999, although
approximately two-thirds of the doctors were still unwilling
to provide this. This result might be due to actual accept-
ance of hastening death at the end-of-life, better knowledge
regarding the use of opioids or both. It is now known that
clinically relevant respiratory failure is not a problem when
opioids are titrated against cancer pain [35]. Since 1999,
there has been growing evidence that the use of opioids for
symptom control in advanced diseases has no effect on sur-
vival and even high doses of opioids do not seem to shorten
life during end-of-life care [20, 21]. In a study conducted in
the Netherlands, physicians administered similar dosages of
opioids in 1995, 2001 and 2005; however, compared
with previous years, in 2005, they thought that life was
shortened by opioids or their intension was to hasten
death by administering opioids less frequently [16]. On
the other hand, high doses of opioids do cause respiratory
depression [17–19], and the potential of opioid to hasten
death during end-of-life care is almost impossible to study
with prospective randomized trials. Although we did not
ask the intention behind physicians’ willingness to increase
the morphine dose, it was clearly stated in the patient
Table 4 Different background factors, life values and attitudes explaining physicians’ decision to increase the morphine dose
(n = 323) versus not (n = 767) in forward logistic regression analysis
n OR (95% CI) P-value
Year of the survey
1999 578 ref.
2015 512 1.40 (1.05, 1.88) 0.024
Sex
Female 534 ref.
Male 556 1.51 (1.11, 2.05) 0.009
Age 1090 1.02 (1.01, 1.04) 0.007
Own advance directive
No 1026 ref.
Yes 64 1.74 (1.00, 3.03) 0.051
Faith in God
Important 489 ref.
Not important 601 1.64 (1.23, 2.19) 0.001
Assisted suicide is reprehensible (VAS) 1090 1.13 (1.08, 1.19) < 0.001
Physicians can’t estimate cancer pain (VAS) 1090 0.94 (0.89, 0.99) 0.021
Physician groups 0.014
Oncologists 120 ref.
Surgeons 252 2.50 (1.40, 4.46) 0.002
Internists 268 2.37 (1.34, 4.20) 0.003
GPs 450 2.30 (1.33, 3.97) 0.003
ref, reference
VAS, visual analogue scale
GP, general practitioner
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scenario that increasing the dose might lead to the patient’s
death. Oncologists were most reluctant to provide the dose
increase, and their opinion did not change between 1999
and 2015. However, they were probably the most familiar
with the influences of opioids in clinical practice as well as
the studies on this issue. Our results reflect that surgeons,
internists and GPs have become increasingly willing to has-
ten death according to a patient’s wishes today than they
were 16 years ago, although improved knowledge on the
low risk of using opioids during end-of-life care probably
influenced our results.
Our results are in line with the study by Miccinesi et al.
in which oncologists were the least in favour of using
lethal drugs [22]. In our study, the difference between
oncologists and other physician groups remained in the
results of the logistic regression analysis. These findings
might be observed because oncologists take care of these
patients on a more regular basis and are perhaps aware
that a patient’s wish to hasten death does not always imply
a genuine wish to die, but might be the result of over-
whelming emotional suffering [36], which could be re-
lieved by therapy.
Religion has been confirmed to have a tremendous
effect on end-of-life decisions and attitudes towards
euthanasia and PAS [1, 22, 27]. In the present study,
faith in God was also found to decrease physicians’ will-
ingness to administer potentially lethal morphine dose.
The number of physicians who had faith in God is lower
in the present survey than in 1999, which might be one
reason for the increasing support for euthanasia and has-
tened death. In a previously mentioned study, Löfmark et
al. concluded that a non-religious philosophy of life
increased physicians’ willingness to perform euthanasia
and PAS, possibly by emphasizing patient autonomy [27].
Advance directives were relatively uncommon among
physicians, but having one seemed to increase the willing-
ness to double the morphine dose; however, the influence
of advance directives did not quite reach statistical signifi-
cance in our logistic regression analysis. To our know-
ledge, the influence of doctors’ own advance directives on
end-of-life decisions has not been previously reported.
We suggest that completing an advance directive for
oneself may lead to greater acceptance of death, even if
this is hastened in a situation without hope for a cure.
Male sex and older age were independently associated
with physicians’ willingness to double the morphine dose.
Previous studies on these factors are somewhat controver-
sial. Females have been shown to be less supportive towards
ending life without explicit request from the patient, but
also to be more supportive of alleviating pain and other
symptoms regardless of the possible life-shortening effects
[22, 26]. In general, younger physicians accept PAS more
often but are less willing to withdraw life-prolonging treat-
ments than older physicians [2, 22, 26]. The exact reasons
why age and sex are related to the tendency to administer
potentially lethal morphine dose in our study remains un-
known, but perhaps more experienced physicians do not
believe that such a morphine dose would actually kill
the patient. Furthermore, men are reported to approve
of assisted death more often than women in the general
population [1].
Developments in medicine have allowed many interven-
tions for patients with very advanced diseases, but the low
survival rates for cardiopulmonary resuscitation (CPR) in
the cancer population have not changed [37]. Further-
more, advanced care planning, which increases the preva-
lence of do-not-resuscitate orders, is probably a more
common practice today than in the 1990’s [31, 38]. In our
study, physicians’ willingness to start CPR in a patient
with very advanced cancer was relatively low and did not
change over the study years, in a contrast to the more eth-
ically difficult and complex attitude regarding hastening
death. Of interest, the decision about CPR did not influ-
ence physicians’ willingness to hasten death through the
dual effect of a high morphine dose. We suggest that phy-
sicians’ willingness to hasten death is mainly related to
their personal attitudes and values rather than medical
facts, which probably guide the decision to withhold CPR.
Finally, we should state that changes in the surrounding
society, general attitudes and clinical decision-making in
Finland and Europe since the 1990s might have had a sub-
stantial influence on our results. In a large international
study, the use of lethal doses of drugs after the explicit re-
quest of a patient with a terminal illness and uncontrolled
symptoms was accepted by 35–78% of physicians, depend-
ing on the country [22]. This large range describes the cul-
tural influence on the difficult decision to hasten death,
but the numbers are quite similar to those found in our
study. Public attitudes towards assisted death have chan-
ged since the 1990s to become more permissible, which
has led to legalization of assisted death in some countries
and increased political support for it in Finland [1, 2]. At
the same time, knowledge and awareness of palliative care
have grown in Finland through national and international
recommendations [39–41]. However, this has happened
later than in some other European countries such as the
UK [3, 4]. In addition, patient autonomy and shared de-
cision- making in treatment-choices are increasingly em-
phasized as important ethical principles throughout
Western countries [5, 6, 42]. Patients’ rights regarding treat-
ment decisions were incorporated into Finnish law in 1992,
and respecting the patient’s wishes is currently one of the
main principles in the ethical guidelines of the Finnish Med-
ical Association [8, 9]. This social and cultural context to-
gether with the shift from paternalism towards a more
patient-centred approach in clinical decision-making prob-
ably influenced the responding physicians’ considerations on
the reprehensibility of hastened death and their willingness
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to comply with patients’ requests in the ethically complex
situation in our study [6, 43].
Strengths and limitations of the study
Limitations of this study need to be acknowledged. Our
response rate (56%) is a limitation even though our study
population is large and the response rate is higher than
that in many recent studies [44–46]. The study population
is also a representative sample, as it reflects the overall
distribution of specialities and gender among Finnish
physicians [47]. The follow-up period is long enough to
detect relevant changes in attitudes and decision-making.
Answers to the hypothetical scenarios might differ from
the decisions made in clinical practice, but these questions
are difficult to study in real life situations.
Conclusions
Considering a hypothetical case scenario, Finnish physi-
cians accepted the risk of hastening death more often in
2015 than in 1999. The specialty of the physician, gender,
and faith in God strongly influenced their acceptance to
this practice. Oncologists were the most reluctant of all
the specialists studied to hasten death. Euthanasia, but not
assisted suicide, was considered slightly less reprehensible
in 2015. Relieving suffering, while considering the justi-
fication to hasten death, is a complex ethical question.
Therefore, both training in medical ethics and medicine
are needed for high quality end-of-life care.
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